BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8328242)

  • 1. The positive peritoneal effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
    DiBonito L; Falconieri G; Colautti I; Bonifacio D; Dudine S
    Acta Cytol; 1993; 37(4):483-8. PubMed ID: 8328242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.
    DiBonito L; Falconieri G; Colautti I; Bonifacio D; Dudine S
    Acta Cytol; 1992; 36(3):329-32. PubMed ID: 1580116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions.
    Shield PW; Koivurinne K
    Cytopathology; 2008 Aug; 19(4):218-23. PubMed ID: 17916095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
    Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
    Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positive and negative false diagnosis of cancer detected by autopsy (author's transl)].
    Grosse H
    Arch Geschwulstforsch; 1980; 50(8):794-800. PubMed ID: 7224822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric differences between cytologically benign and malignant serous effusions.
    Gavin FM; Gray C; Sutton J; Clayden AD; Banks RI; Bird CC
    Acta Cytol; 1988; 32(2):175-82. PubMed ID: 2450434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions.
    Illei PB; Ladanyi M; Rusch VW; Zakowski MF
    Cancer; 2003 Feb; 99(1):51-6. PubMed ID: 12589646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytopathology of exocrine pancreatic carcinoma in effusions.
    Di Bonito L; Dudine S; Falconieri G
    Acta Cytol; 1991; 35(3):311-4. PubMed ID: 1710404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary effusion lymphoma: cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8.
    Wakely PE; Menezes G; Nuovo GJ
    Mod Pathol; 2002 Sep; 15(9):944-50. PubMed ID: 12218212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
    Ong KC; Indumathi V; Poh WT; Ong YY
    Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 9p21 Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis.
    Onofre FB; Onofre AS; Pomjanski N; Buckstegge B; Grote HJ; Böcking A
    Cancer; 2008 Jun; 114(3):204-15. PubMed ID: 18306350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one institution, including post-intraperitoneal hyperthermic chemotherapy findings.
    Patel NP; Taylor CA; Levine EA; Trupiano JK; Geisinger KR
    Am J Clin Pathol; 2007 Sep; 128(3):414-22. PubMed ID: 17709315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
    Afify A; Lynne LC; Howell L
    Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effusion cytology of hepatocellular carcinoma.
    Falconieri G; Zanconati F; Colautti I; Dudine S; Bonifacio-Gori D; Di Bonito L
    Acta Cytol; 1995; 39(5):893-7. PubMed ID: 7571966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of cytologic peritoneal washings.
    Willett GD
    Clin Lab Med; 1985 Jun; 5(2):265-74. PubMed ID: 3896625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
    Dermawan JKT; Policarpio-Nicolas ML
    Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.